Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

2024/05/21 by Maximilian Huttasch, Michael Roden, Sabine Kahl +1 · 1 citation
Medicine · #Liver Disease Diagnosis and Treatment #Diet, Metabolism, and Disease #Diet and metabolism studies

paper · pdf · doi:10.1016/j.metabol.2024.155937

Citations

• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
• Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
• Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
• Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
• Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
• The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study

Cited by

• Beyond Glucose—Rethinking Prediabetes for Precision Prevention